Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1320363, author = {Křenová, Zdenka and Štěrba, Jaroslav and Tvrdíková, Eliška and Křen, Leoš}, booktitle = {Fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma}, keywords = {T-cell lymphoblastic lymphoma}, language = {eng}, title = {Expression of VEGF-A by neoplastic cells in T-cell lymphoblastic lymphoma: possible therapeutic implications related to immunomodulatory properties of this cytokine}, year = {2015} }
TY - CONF ID - 1320363 AU - Křenová, Zdenka - Štěrba, Jaroslav - Tvrdíková, Eliška - Křen, Leoš PY - 2015 TI - Expression of VEGF-A by neoplastic cells in T-cell lymphoblastic lymphoma: possible therapeutic implications related to immunomodulatory properties of this cytokine KW - T-cell lymphoblastic lymphoma N2 - Background: VEGF-A, well known for its mechanistic angiogenic effect and as a target for antiangiogenic therapeutic drugs, has also potent immunomodulatory characteristics. Namely, it contributes to blockade of dendritic cells maturation and increases a number of regulatory T lymphocytes (Treg’s) in blood and tumor tissues. Conclusion: We found expression of VEGF-A in a majority of cases of T-LL. Because of known immunosuppressive properties of VEGFA, possible adding of antiangiogenic drugs to therapeutic armamentarium in T-LL appears warranted. ER -
KŘENOVÁ, Zdenka, Jaroslav ŠTĚRBA, Eliška TVRDÍKOVÁ a Leoš KŘEN. Expression of VEGF-A by neoplastic cells in T-cell lymphoblastic lymphoma: possible therapeutic implications related to immunomodulatory properties of this cytokine. In \textit{Fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma}. 2015. ISSN~0007-1048.
|